Showing results for:

Phase 2 of Gas-to-Energy project can be done in two years – Jagdeo

Guyana's Vice President Bharrat Jagdeo said Phase 2 of the Gas-to-Energy project can be completed in two years.  “We believe that is an outside limit,” he said during a press conference in Georgetown on September 26, following the publication...

US$19 billion to be added to Exxon, co-venturer’s US$7 billion cost bank

ExxonMobil and its co-venturers, Hess and CNOOC, are set to add US$19 billion to their cost recovery bank, in addition to the approximately US$7 billion that remains to be recovered from existing investments in the prolific Stabroek Block offshore...

Second phase of Berbice training facility for completion in 2025

Authorities in Guyana are pursuing the second phase of a training facility in Berbice with support from ExxonMobil, slated for completion in 2025. The first phase, a simulator for floating production, storage and offloading (FPSO) vessels, was commissioned in...

Guyana’s seventh deepwater project to create over 1,300 jobs

The proposed Hammerhead development is set to create up to 1,380 jobs, preliminary estimates from ExxonMobil indicate.  The jobs span four stages of the project.  A project summary filed with the Environmental Protection Agency (EPA) indicates that approximately 540 persons would...

Guyana’s biggest FPSO by target production to set sail in H1 2025

Guyana is set to welcome a trailblazing new floating production, storage and offloading (FPSO) vessel next year. The ONE GUYANA vessel, being constructed by SBM Offshore, is targeting the highest initial oil production observed in the industry for an...

Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Mycosis Fungoides

In heavily pretreated patients with mycosis fungoides, treatment with lacutamab results in meaningful anti-tumor activity regardless of baseline KIR3DL2 expression level. Lacutamab was well-tolerated with a safety profile consistent with prior studies. Innate will host a virtual KOL event on...

Shionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive Worldwide License Agreement for MZE001, a Novel Therapeutic Candidate for the Treatment of Pompe...

Agreement Adds to Shionogi’s Growing Pipeline in Rare Disease MZE001 has the Potential to be the First Oral Therapy for Pompe Disease OSAKA, Japan & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao...

UroGen Announces Results from ATLAS Showing Robust UGN-102 Durability of Response in New and Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer at AUA 2024

New and Recurrent Patients Treated with UGN-102 Achieved Similar Durability of Response Rates (DOR) at 12 months PRINCETON, N.J--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers,...

“It is one of the most incredible success stories” – Mallon on Guyana’s oil development 

The story of Guyana being just a tiny South American country to one of the most prolific oil producers in the world is remarkable, according to ExxonMobil Upstream President, Liam Mallon.  During his CERAWeek 2024 presentation, Mallon said, “It is...

SBM Offshore’s footprint in Guyana growing larger; 51 new vendors added in 2023

Fifty-one Guyanese companies were added to SBM Offshore Guyana’s vendor database in 2023, according to Garri Fraser, the company’s Local Content Officer.  Fraser gave insight on SBM Offshore’s local content strides, during the company’s 'Let’s Talk Local Content’ Seminar, held...

Latest News

GranMorgu FPSO construction hits 27% as Suriname targets first oil by 2028

Construction of the floating production, storage and offloading (FPSO) platform for Suriname’s GranMorgu project has reached 27%, state oil...